Owlstone Medical
Business Services · United Kingdom · 201-500 Employees
View Company Info for Free
Overview
Headquarters
183 Cambridge Science Park Milton Rd, Ca...Phone Number
+44 1223428200Website
www.owlstonemedical.comRevenue
$54.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Owlstone Medical
Owlstone Medical is developing a breathalyzer for disease. With a goal of finding ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health, and other conditions. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine.Explore more
Owlstone Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Owlstone Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Owlstone Medical is spiking on competitors!
Funding: Get notified immidiatlly once Owlstone Medical has new funding data
Product Launch: Get notified when Owlstone Medical launches new products
Click to see if Owlstone Medical had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Owlstone Medical recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Owlstone Medical
Owlstone Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Owlstone Medical has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Owlstone Medical
Compare insights from companies similar to Owlstone Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$44.8M
51-200
Private
$98.9M
2009
Gwenne HenricksChief Technology Officer & Technology Vice President, Product Development
Company Profile Activity
Activity Insights
Owlstone Medical is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Owlstone Medical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Owlstone Medical.
Owlstone Medical financials insights
Gather financial insights about Owlstone Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$679K
2017
Other Financing Round
$11.6M
2018
Other Financing Round
$15M
2020
Debt
$150K
2021
Debt
$166K
2024
Grant
$1.5M
Other Financing Round
$5M
2025
Series E
$27M
Owlstone Medical Tech Stack
A closer look at the technologies used by Owlstone Medical
Most Recent Scoops
Person-Based
Funding
Funding
Event
Product Marketing, Events, Research & Development, Medical Research, Clinical Operations, Healthcare Technology
Funding
Funding
Funding
Funding
Owlstone Medical News & Media
Owlstone Medical wins up to $49.1M ARPA-H award to pioneer breath-based cancer detection
UK medtech Owlstone Medical has won an award of up to $49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) for the Platform Optimising SynBio for Early Intervention and Detect...Partners Group invests €400M in Green Flexibility, Cera secures €145.5M, Tamturbo bags ...
This week, we’ve rounded up some of the news stories that slipped through our radar from January 13th to 17th.Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round
CAMBRIDGE, England--(BUSINESS WIRE)--Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced a first closing of $27 million (circa £22 million) in its Series E financing round. The fundraise was led by Ventura Capital, joined by Aviva Ventures, Horizons Ventures, and other existing investors. The close also saw completion of the investment from the Gates Foundation1. The funds will be used to supportOwlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas
CAMBRIDGE, England--(BUSINESS WIRE)--Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has entered into a Research Collaboration Agreement with the FDA’s Center for Devices and Radiological Health (“CDRH”) - Office of Science and Engineering Laboratories (OSEL). The goal of the collaboration is to develop methods for the confident identification of individual chemicals in the complex mixture
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Owlstone Medical
Sign Up For FreeTo access detailed company insights
Owlstone Medical is developing a breathalyzer for disease. With a goal of finding ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health, and other conditions. Our mission is to save 100,000 lives and $1.5B in healthcare costs by advancing early detection and precision medicine.... Read More
